NCT07698639Completed
Anti-Gravity Treadmill and Electromagnetic Stimulation in Stroke Rehabilitation
Efficacy of Post-Stroke Rehabilitation Using an Anti-Gravity Treadmill and High-Intensity Electromagnetic Stimulation: A Prospective Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if adding new technologies to standard therapy helps people recover after a stroke. It looks at adults aged 18 to 74 who recently had a stroke and need help with moving and walking. The main questions the study aims to answer are: Does adding anti-gravity treadmill training to standard physical therapy improve balance and walking ability? Does adding high-intensity electromagnetic therapy to the treadmill program further help lower muscle stiffness and improve movement? Are these combined exercise treatments safe for the participants? Researchers will compare three groups of participants to see which combination works best: Group 1 receives standard physical therapy and anti-gravity treadmill training. Group 2 receives standard physical therapy, anti-gravity treadmill training, and electromagnetic therapy. Group 3 receives standard physical therapy only. Participants will: Complete standard physical and daily living therapy for three to four hours a day, five days a week. Exercise on a special treadmill that uses air pressure to support their body weight (Groups 1 and 2 only). Receive a 15-minute electromagnetic stimulation treatment on their leg muscles 10 times over two weeks (Group 2 only). Take movement, balance, and walking tests at the start and at the end of the two-week program.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 105 (actual)
- First submitted
- 7 Jul 2026
- Start date
- Jan 2026
- Primary completion date
- May 2026
- Lead sponsor
- BTL Industries Ltd.
- Diseases
- Stroke
- NCT number
- NCT07698639
What you commit to
- Study type: Interventional
- Participants enrolled: 105
- From Jan 2026 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- rapidly progressive neurological deficit, unstable cardiovascular or respiratory system condition, contraindications to physical exercise.
Who the study is looking for
- verified diagnosis of ischemic or hemorrhagic stroke according to neuroimaging data (computed tomography or magnetic resonance imaging;
- age 18;
- Rankin Scale score of 3-4 upon admission;
- ability to obtain informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samara City Clinical Hospital No. 2 Coordinator of this site? Confirm its status | Samara | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.